HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luke McAlary Selected Research

Superoxide Dismutase-1

5/2024Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-1.
1/2024Evaluating protein cross-linking as a therapeutic strategy to stabilize SOD1 variants in a mouse model of familial ALS.
1/2023ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis.
1/2020Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.
1/2020Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.
1/2019CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1.
1/2019Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis.
10/2018Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells.
1/2018The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation.
11/2013Glutathionylation potentiates benign superoxide dismutase 1 variants to the toxic forms associated with amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luke McAlary Research Topics

Disease

19Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2024 - 11/2013
6Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 01/2019
3Sarcoma (Soft Tissue Sarcoma)
01/2023 - 01/2019
1Frontotemporal Dementia (Semantic Dementia)
01/2023
1Disease Progression
01/2021
1Brain Neoplasms (Brain Tumor)
11/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020
1Amyloid angiopathy
01/2020
1Neuroinflammatory Diseases
01/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Huntington Disease (Huntington's Disease)
01/2020
1Inflammation (Inflammations)
01/2020
1Neuroblastoma
01/2020
1Parkinson Disease (Parkinson's Disease)
01/2020

Drug/Important Bio-Agent (IBA)

10Superoxide Dismutase-1IBA
05/2024 - 11/2013
9Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2018
4DNA-Binding Proteins (DNA Binding Protein)IBA
01/2023 - 01/2017
4PrionsIBA
01/2020 - 01/2019
2RNA-Binding Proteins (RNA-Binding Protein)IBA
02/2024 - 01/2019
2UbiquitinIBA
01/2023 - 11/2020
2CuATSMIBA
01/2022 - 01/2021
1EnzymesIBA
05/2024
1Oxygen (Dioxygen)IBA
05/2024
1Free RadicalsIBA
05/2024
1CopperIBA
01/2021
1ThuliumIBA
11/2020
1thulium oxideIBA
11/2020
1OxidesIBA
11/2020
1Protein AggregatesIBA
01/2020
1Heat Shock Transcription FactorsIBA
01/2020
1ApolipoproteinsIBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1HDL LipoproteinsIBA
01/2020
1Amyloid beta-PeptidesIBA
01/2020
1Scavenger Receptors (Scavenger Receptor)IBA
01/2020
1InflammasomesIBA
01/2020
1Prion ProteinsIBA
01/2019

Therapy/Procedure

1Therapeutics
01/2019